Gender Equality and Diversity at HT – Symposium
The first symposium on “Gender Equality and Diversity at HT” took place today at the Human Technopole Auditorium. The aim of the event was to discuss why there are differences in the career outcomes of men and women and how we can act to promote equality and inclusion at HT. During the event we heard from Gerlind Wallon, Deputy Director of the European Molecular Biology Organisation (EMBO) and Saher Ahmed, Head of Diversity Equality and Inclusion at the Sanger Institute. The aim is to start a conversation on how both our personal actions and institutional policies can best promote equality and inclusion at Human Technopole.
PROGRAMME
14.00 – 14.05: Welcome to HT. GIANMARIO VERONA (President, HT)
14.05-14.15: Introduction. NICOLE SORANZO (Head of Genomics Research Centre, Population & Medical Genomics, HT)
14.15-14.45: «Gender in Academia». GERLIND WALLON (Deputy Director, EMBO)
14.45-15-15: «Our journey in Equality, Diversity and Inclusion». SAHER AHMED (Head of Equality, Diversity and Inclusion, Sanger Institute )
15.15-15.45: Q&A session. NICOLE SORANZO (Head of Genomics Research Centre, Population & Medical Genomics, HT)
15.45-16.15: COFFEE BREAK
16.15-16.30: «HT Gender Equality Plan and Gender Equality Team at HT». ALESSANDRA POGGIANI (Director of Administration, HT)
16.30-16.50: Ideas for the future. Chaired by NICOLE SORANZO, GERLIND WALLON , SAHER AHMED, ALESSANDRA POGGIANI
16.50-17.00: Closing Remarks
Share:
You could also like:
-
Colorectal Cancer: ML Enhances Cetuximab Response Predictions
An international collaborative study led by Human Technopole, Candiolo Cancer Institute IRCCS in Turin, the University of Turin, and the Wellcome Sanger Institute in Cambridge (UK) has identified new factors associated with therapeutic response in colorectal cancer. The research has led to the development of a machine-learning model capable of accurately predicting the effects of cetuximab, a drug in clinical use, on different colorectal tumour subtypes. Funded by the AIRC Foundation, the study paves the way to identifying molecular features that could serve as biomarkers for predicting treatment response in patients with this type of cancer.
-
Human Technopole Foundation’s Supplier List online
The Human Technopole Foundation’s Supplier Register is now online.
-
HT Director Zerial Awarded Mercurio Prize for Excellence in Research
The Human Technopole Director, Marino Zerial, has been awarded the 2024 Mercurio Prize in the “Research and Development” category, in recognition of the excellence of his research in the field of cell biology. Zerial, renowned for his studies on the mechanisms of endocytosis and cellular transport, has made significant contributions to the understanding of cellular dynamics, with potential therapeutic applications for diseases such as liver conditions.
-
A new model system for cortical development in vitro
Researchers from Human Technopole, the Institute of Molecular Biotechnology and Bicocca University established a method for developing brain assembloids that allows reproducing salient aspects of the antero-posterior polarity of the human cerebral cortex in vitro and opens new possibilities for disease modelling. The study is published in Nature Methods.
-
The National Facility for Genomics with Clelia Peano
Meet Clelia Peano, Head of the National Facility for Genomics. The Facility offers cutting-edge services to develop robust experimental and analytical workflows to explore different genomic research areas, including DNA and RNA analysis, chromatin structure, and epigenetic mechanisms regulating transcription. The goal is to enhance genomic research in all its aspects, benefiting the entire Italian scientific community.